GENZYME

Related by string. Genzyme * * Henri Termeer Genzyme . Genzyme GENZ . Genzyme NASDAQ GENZ . Genzyme Nasdaq GENZ . BioMarin Genzyme LLC . Genzyme cautions . CAMBRIDGE Mass. Genzyme . Genzyme Quarterly Report . Genzyme Biosurgery . Genzyme Henri Termeer . consent decree Genzyme . Genzyme Cerezyme . Genzyme nasdaq GENZ . Genzyme NasdaqNM GENZ . Genzyme Corp GENZ.O . Genzyme GENZ.O *

Related by context. All words. (Click for frequent words.) 76 NOVARTIS 74 BIOTECHNOLOGY 73 CEPHALON 73 FDA APPROVES 73 PHARMACEUTICALS 72 DIAGNOSTICS 71 BIOGEN IDEC 71 WYETH 70 AUDIO PROVIDED BY 70 THERAPEUTICS 70 HEALTHCARE SERVICES 70 COMUNICADO DE 70 PHARM 70 ANNOUNCES APPOINTMENT OF 69 GLAXOSMITHKLINE 69 PHASE III 69 COLLABORATION WITH 69 BIOSCIENCES 69 CELGENE 69 HUMAN GENOME SCIENCES 69 BIOPHARMA 68 PHARMACEUTICALS INC. 68 COMPLETES ACQUISITION OF 68 WORLDWIDE INC. 68 ABBOTT LABORATORIES 68 HONEYWELL INTERNATIONAL 67 CLINICAL DATA 67 ASTRAZENECA 67 Therapeutic Competitors companiesandmarkets.com adEgemonye 67 REPORTS FIRST QUARTER 67 PHARMACEUTICALS INC 67 PITNEY BOWES 67 CORP. ANNOUNCES 67 POLYMERS 67 EPS ESTIMATES FOR 66 FOLLOWING LAST YEAR 66 BIOSCIENCE 66 Metabasis Therapeutics 66 GROUP THE TREND 66 GILEAD SCIENCES 66 REPORTS THIRD QUARTER 66 ANNOUNCES RECORD 66 CALPINE 66 BOSTON SCIENTIFIC 66 ENDO PHARMACEUTICALS 65 Nasdaq PARD 65 PENNY STOCK ON 65 BIOTECHNOLOGY SOURCE 65 Nasdaq ACHN 65 PFIZER INC. 65 Regeneron Pharma 65 COVIDIEN 65 Idera Pharmaceuticals 65 MBRX 65 Therapeutic Competitors Companies 65 Transcept Pharmaceuticals 65 CONTINUES UP 65 LOUISMO 65 SHARES FALL 65 DRRX 65 Aestus Therapeutics 65 Nasdaq IDIX 65 TECHNOLOGY INC 65 CO INC 65 DVAX 65 Barrier Therapeutics Inc. 65 MEDICAL SYSTEMS 65 ACADIA Pharmaceuticals 65 Alexion Pharma 65 NOVAVAX 65 DOWNGRADE ALERT WATCH FOR 64 Initiates Clinical Trial 64 CONTINUES HIGHER 64 CONTINUES DOWN 64 THER 64 Nasdaq HALO 64 ANIK 64 Alnylam Pharmaceuticals Inc 64 ANNOUNCES PARTNERSHIP WITH 64 STOCK RISES 64 ARYX 64 Isis Pharma 64 MANAGEMENT CHANGES SOURCE 64 SHAREHOLDERS APPROVE 64 NEW YORKNY 64 THE RUN DOWN 64 Catalyst Biosciences 64 TRADING LOWER ON #.#X 64 IPSEN 64 INTERNATIONAL THE TREND 64 Nymox Pharmaceutical 64 Therapeutic Competitors 63 AFFYMETRIX 63 ALIM 63 PRODUCTS INC. 63 Flamel Technologies 63 CHANGES SOURCE 63 Idenix Pharmaceuticals 63 SGMO 63 Optimer Pharmaceuticals Inc 63 Repligen Corporation 63 Nasdaq ACAD 63 THERAPEUTICS INC 63 CRXL 63 Protalix Biotherapeutics Inc. 63 Pharmos Corporation 63 NGSX 63 Ltd. OTCBB IMUC 63 Alnylam Nasdaq ALNY 63 ANNOUNCES ACQUISITION OF 63 TRBN 63 Exploit collaboration 63 CALL VOLUME UP 63 Receives Orphan Drug Designation 63 AMEX RGN 63 Initiates Enrollment 63 KOSN 63 'S LOSSES 63 DUKE ENERGY 63 Ohr Pharmaceutical Inc. 63 Genome Therapeutics 63 Supernus Pharmaceuticals Inc. 63 Corp. Nasdaq GENZ 63 NSTK 63 NYSE Amex PBTH 63 THE TREND CONTINUES DOWN 63 SHARES DROP 63 Auxilium Pharmaceuticals Inc 63 Files IND 63 Cypress Bioscience Inc 63 STENT 63 FoldRx Pharmaceuticals Inc. 63 THE TREND CONTINUES LOWER 63 HEPH 62 Initiates Clinical Trials 62 Alnara Pharmaceuticals 62 Nasdaq VRTX today 62 RDYN 62 SENO 62 AGREEMENTS SOURCE 62 By JAMAAL ABDUL 62 Nasdaq MBRX 62 Nasdaq TARG 62 Vion Pharmaceuticals 62 Psivida 62 KAI Pharmaceuticals 62 LGND 62 INTERACTIVE ENTERTAINMENT 62 Akorn Inc 62 OSUR 62 KV.A 62 3X AS TRADERS 62 IDIX 62 SHP.L 62 Initiates Clinical 62 EXPANDS ITS 62 Avila Therapeutics 62 Nasdaq ACOR 62 LORILLARD 62 AUXL 62 Ingenium Pharmaceuticals AG 62 DISTRIBUTION AGREEMENT WITH 62 INTL INC 62 Nasdaq DVAX 62 THE HUMAN RESOURCE 62 Emisphere Technologies 62 SMARTREND RESEARCH REPORT AVAILABLE 62 AviaraDx 62 Cyclacel Pharmaceuticals 62 TRACON Pharmaceuticals 62 Onyx Pharmaceuticals Inc 62 Nasdaq REGN 62 OTCBB ADXS 62 TapImmune Inc. 62 Senesco Technologies 62 SOLVAY PHARMACEUTICALS 62 CureDM 61 Nasdaq CYCC 61 OTCBB AFLB 61 NASDAQ CORT 61 OTCBB AMAR 61 Syntonix Pharmaceuticals 61 Ascenta Therapeutics 61 BENETTON 61 OTCBB EMIS 61 Osiris Therapeutics Inc 61 STOCK RISES #.# 61 VentiRx Pharmaceuticals 61 NASDAQ INFI 61 Therion Biologics 61 Submits NDA 61 Roche OTC RHHBY 61 Inc. Nasdaq COLY 61 OTCBB IMUC 61 TKPHF 61 ENTREE GOLD 61 Alnylam Pharma 61 Indevus Pharma 61 Myrexis Inc. 61 Begins Dosing 61 CRXX 61 KYTHERA Biopharmaceuticals Inc. 61 Nasdaq SHPGY 61 ALNY 61 PERRIGO 61 Genelabs Technologies 61 ROSG 61 Taligen Therapeutics 61 Corcept Therapeutics Incorporated 61 Initiate Clinical Trial 61 Tezampanel 61 SHARES SLIDING LOWER DOWN 61 Announcement acc 61 OTCBB FCSC 61 Regeneron Pharmaceuticals Inc 61 MLNM 61 Therapeutic Competitors Report 61 IG HCR ;) CO 61 SIGNING LOW OF 61 ENZN 61 AFX Biopharmaceutical 61 Ercole Biotech 61 OMRIX Biopharmaceuticals Inc. 61 Hybridon 61 FALLS BELOW 3 61 www.ucb group.com 61 BRANDS INC. 61 CONTINUES LOWER 61 Momenta Pharmaceuticals MNTA 61 ARDM 61 Crucell NV NYSE Euronext 61 Tibotec BVBA 61 Transkaryotic Therapies TKTX 61 non nucleoside inhibitor 61 Enzon Pharmaceuticals Inc 61 markets HP Acthar 61 BPAX 61 Alligator Bioscience AB 61 Receives Approvable Letter 61 Incyte Corp 61 ImmunoGen Inc. 61 EntreMed Inc. 61 NYMX 61 LSE SHP.L 61 DETECTS BEARISH ENGULFING PATTERN 61 MOMENTUM LOOKS TO CONTINUE 61 ViRexx Medical 61 Iomai Corporation 61 Inc Therapeutic Competitors 61 Coley Pharmaceutical Group 61 MultiCell Technologies 61 Initiates Phase II 61 Eurand NV EURX 61 AMEX CTE 61 PROLOR Biotech Inc. 61 NASDAQ CRXL 61 Xytis 61 NPS Pharma 61 WEEK LOW 61 NOVN.VX 61 NASDAQ ONXX 61 Ziopharm Oncology 61 NASDAQ RNAI 61 Inc. OTCBB APNS 61 EPIX Pharmaceuticals Inc. 61 Durect Corporation 61 Xanthus Pharmaceuticals Inc. 61 CRYO 61 SMMX 61 Novelos Therapeutics Inc. 61 NASDAQ DCGN 61 Receive Milestone Payment 61 PRXL 61 DOV Pharmaceutical Inc. 61 FDA Accepts 61 SHARES CREEPING HIGHER UP 60 NOVN 60 ARQL 60 Conatus Pharmaceuticals 60 STRONGLY ADVISES ALL 60 NASDAQ PARD 60 Receives Fast Track 60 CYTR 60 CONFERENCE CALLS SOURCE 60 Archemix Corp. 60 TolerRx 60 Phase IIb Trial 60 Nasdaq ENZN 60 Endo Pharmaceuticals Nasdaq ENDP 60 Nasdaq VRTX 60 Psoriasis Drug 60 Craig Tooman 60 TTHI 60 Progenics Pharmaceuticals 60 Agios Pharmaceuticals 60 Receives Orphan Drug 60 CYTC 60 OTCBB CGXP 60 ZIOP 60 RDEA 60 Nasdaq VNDA 60 Mersana Therapeutics 60 DORB 60 ONCY 60 Oxis International 60 Nasdaq ONXX 60 NASDAQ AEZS 60 Nasdaq AVNC 60 LEAD Therapeutics 60 CDXC 60 Amylin Pharma 60 Mylan Receives Approval 60 Graceway Pharmaceuticals LLC 60 NASDAQ ACAD 60 TO AVOID PREGNANCY WHILE 60 Nasdaq IMGN 60 NASDAQ DRRX 60 Nasdaq PGNX 60 Antigenics NASDAQ AGEN 60 INTERIM RESULTS FOR 60 Javelin Pharmaceuticals Inc 60 AVANT Immunotherapeutics 60 NASDAQ ADLR 60 Fibrocell Science Inc. 60 Milestone Payments 60 Nasdaq CADX 60 Sangamo BioSciences 60 Advancis Pharmaceutical Corporation 60 Nasdaq RDEA 60 ABII 60 NASDAQ IMMU 60 SSRX 60 EPCT 60 Nasdaq CRXL 60 DUSA Pharmaceuticals 60 Nasdaq SOMX 60 Trubion Pharmaceuticals 60 Guides FY# Quick Facts 60 Myriad Genetics Inc 60 CLDX 60 ΞΕΝΗ ΔΗΜΟΣΙΕΥΣΗ ΑΝΑΚΟΙΝΩΣΗInfosys Finacle 60 Ibis Biosciences 60 RegeneRx Biopharmaceuticals Inc. 60 Shire plc SHPGY 60 PXSL 60 CRME 60 PDL BioPharma Inc 60 DOV Pharmaceutical 60 ChemGenex Pharmaceuticals Limited 60 Nasdaq AMAG 60 NASDAQ REGN 60 PSDV 60 NovaDel Pharma 60 Trubion Pharmaceuticals TRBN 60 KEYWORD PHARMACEUTICAL 60 AEROPOSTALE 60 Licenses Novel 60 NASDAQ EPIX 60 Raven Biotechnologies 60 HERTZ GLOBAL 60 MBRK 60 GlaxoSmithKline plc GSK 60 CELANESE 60 NASDAQ LGND 60 ROTATEQ ® 60 Granted Orphan Drug 60 OTCBB DORB 60 Theraputics 60 MEDW 60 Qiagen NASDAQ QGEN 60 Alnylam ALNY 60 NASDAQ IDRA 60 Completes Patient Enrollment 60 CAPITAL INC. 60 PHST 60 NASDAQ SHPGY 60 Milestone Payment 60 Luveris R Ovidrel R 60 ELGX 60 Nasdaq IDRA 60 ONYX Pharmaceuticals 60 Nasdaq RXII 60 TSRX 60 IMGN 60 Inc. Nasdaq OXGN 59 NSPH 59 Mersana Therapeutics Inc. 59 EURX 59 ORD SHS 59 Sunesis Pharmaceuticals Inc. 59 OTCBB OHRP 59 Initiates Phase III 59 Presents Preclinical Data 59 Adventrx Pharmaceuticals 59 Presents Positive 59 Pernix Therapeutics 59 Quark Biotech 59 AMEX ANX 59 SGXP 59 AVERAGE VOLUME 59 Inc. NASDAQ ORXE 59 Meets Primary Endpoint 59 NASDAQ NVAX 59 Gendux AB 59 Tranzyme Pharma 59 TSX CTI 59 Vicuron Pharmaceuticals 59 Aradigm Corporation 59 Idenix Pharmaceuticals IDIX 59 MEDICAL PHARMACEUTICAL 59 Connetics Corporation 59 Inc. Nasdaq SEPR 59 NASDAQ BSMD medical 59 DAIICHI 59 CRTX 59 OFLX 59 Ligand Pharma 59 Adamis Pharmaceuticals 59 AVEO Pharmaceuticals Inc. 59 ANNUAL FINANCIAL REPORT 59 Albugon 59 Salmedix 59 NASDAQ GENZ 59 Nasdaq DYAX 59 Inspire Pharma 59 Biogen Idec NASDAQ BIIB 59 Xenoport Inc. 59 Trubion Pharmaceuticals Inc. 59 WEEK HIGH RECENTLY ECLIPSED 59 Targanta Therapeutics Corporation 59 Merrimack Pharmaceuticals 59 Progenics Pharmaceuticals Inc 59 Xenogen Corporation 59 NASDAQ BSMD 59 NASDAQ KERX 59 OMRIX Biopharmaceuticals 59 NASDAQ ISIS 59 SNMX 59 CeNeRx BioPharma 59 Anticancer Agent 59 Protalix BioTherapeutics Inc. 59 Generex Biotechnology 59 NASDAQ EMIS 59 REACHES INITIAL SUPPORT LEVEL 59 NASDAQ TSPT 59 NASDAQ SCLN 59 PVCT 59 FOLOTYN ® 59 #M MarketCap [002] 59 Epiphany Biosciences 59 EXPLORATION LTD 59 Nasdaq KERX 59 Nasdaq AUXL 59 Pharmacopeia PCOP 59 LXRX 59 VISTEON 59 Biotherapeutic 59 NASDAQ PANC 59 AMEX ISV 59 DEVON ENERGY 59 UGNE 59 OPTR 59 NBIX 59 Inc. Nasdaq IMGN 59 NASDAQ AVNR 59 NASDAQ BIIB 59 NASDAQ HALO 59 NASDAQ INCY 59 Vertex Pharmaceuticals Inc 59 OTCBB NNVC 59 Nektar Therapeutics NKTR 59 OTCBB NPHC 59 LMNX 59 NASDAQ CYTX 59 OTCBB IMNR 59 Nasdaq FURX 59 NASDAQ ALXN 59 Kuvan R 59 Wellstat Therapeutics 59 NASDAQ PPDI 59 Enzon Pharmaceuticals 59 Vitrasert R 59 ANGN 59 UPTREND CALL 59 NASDAQ OMER 59 NASDAQ BJGP 59 Nasdaq LXRX 59 Interferon beta 1a 59 Initiates Dosing 59 REGN 59 Fabry Disease 59 Inflazyme Pharmaceuticals 59 BAYRY 59 visit http:/www.mannkindcorp.com 59 Revises FY# Outlook 59 Declares Dividend Quick Facts 59 NASDAQ FLML 59 Nasdaq BIIB 59 Acorda Therapeutics ACOR 59 WILLIS GROUP 59 Nasdaq CGEN 59 OTCBB CHKT 59 Prism Pharmaceuticals 58 NYSE MRX 58 Presents Preclinical 58 CRUCELL 58 Dynepo TM 58 INFOSYS TECHNOLOGIES 58 Aerie Pharmaceuticals 58 DYAX 58 otcstockexchange.com 58 PHRM 58 Savient Pharmaceuticals Inc 58 SGX Pharmaceuticals 58 SPECULATE ON HIGHER PRICES 58 Amex ANX 58 SET TO PULLBACK AFTER 58 OTCBB ILNS 58 Patient Enrolment 58 GENR 58 Acuity Pharmaceuticals 58 Supernus Pharmaceuticals 58 Nastech Pharmaceutical Company 58 NovaBay Pharmaceuticals 58 Luitpold Pharmaceuticals 58 Receives Milestone Payment 58 OSIR 58 BIIB BIIB 58 BMRN 58 ONTY 58 MOGN 58 Auxilium Pharma 58 Announce Collaboration Agreement 58 Oxford Genome Sciences 58 Ziopharm 58 Astex Therapeutics 58 Receives CE Marking 58 Initiate Phase 58 NEXM 58 Eyetech Pharmaceuticals 58 Lexicon Pharmaceuticals 58 Enzo Biochem 58 PPD Nasdaq PPDI 58 NASDAQ ARRY 58 Taglich Brothers Initiates Coverage 58 NASDAQ BMRN 58 NASDAQ BDSI 58 Fast Track Status 58 Cytokinetics CYTK 58 Exelixis EXEL 58 Protalix BioTherapeutics 58 Vernalis plc 58 OTCBB IBPM 58 Salix Pharmaceuticals Ltd 58 AFFY 58 Resolvyx Pharmaceuticals 58 Gets FDA Clearance 58 NASDAQ IMGN 58 InNexus Biotechnology 58 OTCBB PYTO 58 Endo Pharmaceuticals ENDP 58 Announces Tentative Approval 58 LifeCell Corporation 58 ImmunoCellular Therapeutics Ltd. 58 AKRX 58 ARCA biopharma Inc. 58 Guides FY# Update 58 INSM 58 OPXA 58 Inc. Nasdaq AVRX 58 GTC NASDAQ GTCB 58 Theravance THRX 58 Anika Therapeutics 58 HIGHER ON #.#X ABOVE 58 NASDAQ PPHM 58 KRYSTEXXA TM pegloticase 58 Halozyme Therapeutics 58 ARCA Biopharma 58 MOVING AVERAGE CROSSOVER ALERT 58 INCY 58 ABIO 58 TASEKO MINES 58 ALTERA 58 OTCBB NPHC biotechnology 58 FoldRx 58 NASDAQ GTCB 58 Antisense Pharma GmbH 58 NYSE BDX 58 Protalex Inc. 58 Acceleron Pharma 58 KAI Pharmaceuticals Inc. 58 Nasdaq MOGN 58 Arqule 58 NASDAQ WCRX 58 Valera Pharmaceuticals 58 BTRX 58 QLTI 58 Cavit Sciences Inc. 58 Nasdaq SGMO 58 PRN FDA Approves 58 Ascent Therapeutics 58 Expanded Indication 58 Nasdaq ICOS 58 Initiates Phase 2b 58 OncoGenex Pharmaceuticals Inc. 58 Commercialize Novel 58 Corporation Nasdaq GENZ 58 Celera CRA 58 Cytori Therapeutics Inc 58 #.#X ABOVE AVERAGE VOLUME 58 IMMU 58 Portola Pharmaceuticals 58 VCRT 58 WR GRACE 58 Aegerion Pharmaceuticals Inc. 58 BSMD 58 Zelos Therapeutics 58 Genelabs Technologies Inc. 58 CardioTech International 58 Cellgate Inc. 58 ILSE 58 plc AMRN 58 RPRX 58 Rigel Pharmaceuticals 58 NASDAQ ACOR 58 CombinatoRx Incorporated 58 Integra Lifesciences 58 Celldex Therapeutics CLDX 58 NASDAQ SLXP 58 NTII 58 Generex Biotechnology Corp. 58 AMEX PTN 58 CITZ 58 CAMBRIDGE Mass. Biotechnology 58 BNVI 58 Maxim Pharmaceuticals 58 Nasdaq THLD 58 Genvec 58 Alexza Pharmaceuticals Inc 58 Idenix Pharmaceuticals Inc 58 NASDAQ VRTX 58 ATHX 58 Scynexis 58 Panacea Pharmaceuticals 58 VTUS 58 Ardea Biosciences 58 Ltd Therapeutic Competitors 58 Electro Optical Sciences 58 Xoma Ltd 58 R MSCRAMM 58 PWRM.OB 58 NASDAQ NRGN 58 AMEX ONI 58 Hana Biosciences 58 Ironwood Pharmaceuticals 58 NASDAQ VVUS 58 Nasdaq IPXL 58 NYSE Amex PTN 58 Vaccine Adjuvant 58 Investigational Compound 57 Migraine Drug 57 SRDX 57 NasdaqGM ADLR today 57 Drug Candidate 57 Nasdaq CLDX 57 Stromedix 57 Nasdaq SNSS 57 Receives Complete Response 57 Phase 2b Clinical Trial 57 Cyclacel Pharmaceuticals Inc. 57 Medivation Inc 57 NASDAQ CALP 57 AMEX DDD 57 OSI Pharmaceuticals NASDAQ OSIP 57 Seattle Genetics SGEN 57 Thermo Fisher Scientific TMO 57 Protalix BioTherapeutics PLX 57 Reports Preclinical Data 57 Enrolls First 57 Successfully Completes Phase 57 Ception Therapeutics 57 Oscient Pharmaceuticals 57 M.D. Ph.D. 57 NASDAQ INGN 57 Rigel Pharmaceuticals RIGL 57 Patient Enrollment 57 SOMX 57 Nasdaq NPSP 57 VIA Pharmaceuticals 57 Nasdaq MYRX 57 Presidio Pharmaceuticals 57 NASDAQ OSCI 57 NASDAQ AVEO 57 CRGN 57 ZGNX 57 Nasdaq AVNR 57 Announce License Agreement 57 Adenosine Therapeutics 57 BioSante Pharmaceuticals Announces 57 NASDAQ ABIO 57 NDA Submission 57 Barr Pharmaceuticals BRL 57 Release Capsules 57 Phase IIb Clinical Trial 57 Indevus Pharmaceuticals 57 Q2 Adj 57 GILD GILD 57 IMRX 57 NRGN 57 Biomarker Study 57 Nasdaq ALNY 57 Submits IND 57 NYSE COV 57 Announces Poster Presentations 57 FDA Approvals 57 Biodel BIOD 57 AMEX PLX 57 Draxis Health 57 Apricus Biosciences 57 Kiadis 57 Adnexus Therapeutics 57 Nasdaq XTLB 57 Nasdaq ALSE 57 Nasdaq ILXO 57 Sign License Agreement 57 Oscient Pharmaceuticals Corp. 57 Vertex Pharma 57 Biocompatibles International 57 Inc. Nasdaq SUPG 57 NUEC 57 BioSpecifics Technologies Corp. 57 TSX NVN 57 Systemic Delivery 57 Cepheid CPHD 57 NASDAQ CERS 57 POWER CORPORATION 57 Rexahn Pharmaceuticals 57 Alantos Pharmaceuticals 57 NASDAQ MNTA 57 Orqis Medical 57 Generex Biotech 57 Nasdaq VVUS 57 Nasdaq BSTE 57 Chroma Therapeutics 57 OTCBB TDLP 57 Cara Therapeutics 57 Abraxis Bioscience Inc. 57 Nasdaq ALTH 57 Pervasis Therapeutics Inc. 57 SR Pharma 57 EYET 57 BioMarin Pharmaceutical 57 OGXI 57 OTCBB NVLT 57 Nasdaq SCLN 57 Merck Sante sas 57 Jumps Higher 57 Campath ® 57 BioMarin Pharmaceuticals 57 Nasdaq EPCT 57 Acorda Therapeutics Inc 57 NASDAQ ENZN 57 AVXL 57 Aveo Pharmaceuticals 57 NASDAQ NURO 57 ProChon Biotech Ltd. 57 NASDAQ ALNY 57 Biodel Inc 57 TRGT 57 THLD 57 Nasdaq AGEN 57 ACHN 57 Aspreva Pharmaceuticals Corporation 57 NYSE Amex RGN 57 Anadys Pharmaceuticals 57 PF # [002] 57 Medicis MRX 57 Embolic Protection 57 Nereus Pharmaceuticals 57 DOWNTREND CALL 57 Nasdaq SGEN 57 Nasdaq SLXP 57 NKBP 57 NASDAQ DIGE 57 NASDAQ CRME 57 Plc Ads SHPGY 57 CRXA 57 Rexahn Pharmaceuticals Inc. 57 NASDAQ PCYC 57 Plethora Solutions Holdings 57 Files Investigational 57 Nasdaq ALXA 57 Inc. Nasdaq INSM 57 ECTE 57 please visit http:/www.vandapharma.com 57 Achieves Primary Endpoint 57 Fovea Pharmaceuticals 57 Nasdaq ADLR 57 RGDX 57 NASDAQ CGPI 57 ASE SVA 57 NYSE AMEX IBIO 57 Protalix Biotherapeutics 57 Cougar Biotechnology Inc 57 VisEn Medical 56 NVGN 56 Herborium Group 56 EMD Biosciences Inc. 56 Altus Pharmaceuticals 56 Namenda Memantine HCl 56 Inc. Nasdaq MITI 56 BFRM 56 Onyx Pharmaceuticals 56 BLP# Liposome Vaccine 56 OTCBB QTXB 56 LEVEL OF EFFICIENCY 56 OTCStockExchange.com Stock Alert 56 NASDAQ ACHN 56 Warner Chilcott plc 56 Presents Positive Preclinical 56 Begins Clinical Trial 56 RXII 56 Nasdaq ENMD 56 Genzyme Corp 56 Nasdaq SPPI 56 Peakdale Molecular 56 CancerVax Corporation 56 MOVIPREP R 56 Insmed Incorporated NASDAQ INSM 56 YESTERDAY 'S RALLY OF 56 THRX 56 Submits Biologics License Application 56 Announce Merger Agreement 56 FLDM 56 Senesco Technologies Inc. 56 Cell Therapeutics Inc 56 Seikagaku 56 Oxxon Therapeutics 56 Viron Therapeutics 56 Submits Response 56 OXGN 56 Vanda Pharmaceuticals Inc 56 QuatRx Pharmaceuticals 56 ISPH 56 NASDAQ VPHM 56 Martinsried Germany 56 ICON plc 56 Medicis Pharmaceutical Corp 56 NASDAQ AVII 56 Curon Medical 56 NPS Pharmaceuticals 56 Cadence Pharmaceuticals Inc 56 Novelos Therapeutics 56 Cubist Pharma 56 Cellegy Pharmaceuticals 56 Eurand Pharmaceuticals 56 Corporation GENZ 56 NASDAQ SIGA 56 Attracting Bullish Investors 56 Insmed Incorporated 56 www.ucb.com 56 Neuroptix 56 CLDA 56 NASDAQ IDIX 56 Optimer Pharmaceuticals 56 Synergy Pharmaceuticals 56 Vaccinex 56 Nasdaq DEPO 56 CAMBRIDGE Mass. Genzyme 56 SUPG 56 ImmunoCellular Therapeutics 56 CyDex Pharmaceuticals 56 Ciphergen Biosystems 56 Nasdaq GENR 56 HELSINN 56 PBIO 56 Alkermes ALKS 56 Senomyx SNMX 56 INTERNATIONAL HOLDINGS INC. 56 Nasdaq BPUR 56 ACLARA BioSciences 56 Xcytrin R 56 Inc. NASDAQ MRNA 56 OSI Pharma 56 Oncobionic 56 Fumapharm AG 56 COLAZAL R 56 ENCY 56 GNLB 56 Report companiesandmarkets.com adds 56 InteKrin Therapeutics 56 Nasdaq DIGE News 56 Inotek Pharmaceuticals 56 Nasdaq MGRM 56 NASDAQ DVAX 56 Personalized Immunotherapy 56 DOWNGRADED ONE WEEK AGO 56 Nasdaq NRGN 56 Nasdaq CYTX 56 VRUS 56 Tibotec Pharmaceuticals Ltd. 56 Talecris Biotherapeutics Holdings 56 NASDAQ CADX 56 Romidepsin 56 SangStat 56 PDL Biopharma 56 Essentialis 56 Nasdaq GNBT 56 ONXX 56 :/ finance.yahoo.com q 56 Frankfurt XMP 56 CTRX 56 HYTM 56 Phase 2a Trial 56 NASDAQ CLDX 56 PANC 56 ViOptix Inc. 56 Beckman Coulter BEC 56 Syntonix 56 Memgen 56 Medisorb ® 56 Sinks Lower 56 OTCBB CVBT 56 Antisoma plc 56 APCVZ 56 ProMetic BioSciences 56 Inc. NASDAQ IDMI 56 YM Biosciences 56 HuMax 56 OPi 56 Corp. ADLR 56 NASDAQ SGMO 56 ZGEN 56 Ichor Medical Systems 56 OTC PVCT 56 Bayer BAYRY 56 Daxor Corporation 56 Intellipharmaceutics International 56 Nexavar sorafenib 56 Endures Analyst Downgrade 56 R Saizen R 56 INHX 56 RHHBY 56 QTXB 56 Inc. NASDAQ OXGN 56 Cephalon NASDAQ CEPH 56 Genentech Roche 56 H.B. Fuller 56 Penwest Pharma 56 Biogen Idec Inc 56 Atherogenics 56 BRUKER 56 CNGL 56 developing Zerenex ferric 56 Osmetech plc 56 Valeant Pharma 56 Rinat Neuroscience 56 RELEASES ITS QUARTERLY NUMBERS 56 Lantibio 56 BMTI 56 RNVS 56 SYN X 56 Sensipar ® 56 Completes Enrollment 56 Alnylam Pharmaceuticals ALNY 56 ASM INTERNATIONAL 56 STOCK EXCHANGE ANNOUNCEMENT #.#.# 56 AstraZeneca MedImmune 56 OTCBB ADMP 56 SCLN 56 Abviva Inc. 56 NASDAQ DSCO 56 OTCBB EVSC 56 NASDAQ MIPI 56 ISTA Pharmaceuticals 55 platform HDL Mimetic 55 Dynogen Pharmaceuticals 55 Onyx Pharma 55 TKTX 55 Extends Collaboration 55 OTC BB PVCT 55 provides RevColor RevDisplay 55 Put Volume Surges 55 dedicated CHAT ROOM 55 Nasdaq ANPI 55 Lexicon Genetics Incorporated 55 Osiris Therapeutics 55 Immunex Corporation 55 Myers Squibb 55 CGRB 55 Sanofi NYSE SNY 55 Gonal f R 55 Oxigene 55 Sunshine Biopharma 55 Medigene 55 Q1 Profit Decreases 55 Nasdaq PANC 55 Taro Receives 55 Hologic HOLX

Back to home page